ANAVEX®2-73 corrects directly to humans’ translatable EEG biomarkers in a model of Fragile X Syndrome (FXS) Therapeutic potential to address...
Presentations will include an encore of the positive interim Phase 1/2 results presented in April at the 76th Annual American...
GARDEN CITY, N.Y., July 23, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a...
U.S. FDA has granted Orphan Drug Designation to SPG601 for the Treatment of Fragile X Syndrome SPG601 is a novel...
Autism testing for kids 4 and under in Arlington Heights, Deerfield, and Naperville fills a much-needed gap for local families.CHICAGO,...
Dr. Michael Oanea Hired to Pediatric Team at Whittier Street Health, Roxbury, MABOSTON, MA / ACCESSWIRE / July 18, 2024...
SciSparc will receive additional payments and execution fees if certain milestones are met TEL AVIV, Israel, July 17, 2024 (GLOBE...
Sarma1 2 Dr. Purnanand Sarma, PhD Press Release Dr. Sarma brings exceptional expertise in all facets of the pharmaceutical and...
According to the agreement, SciSparc’s pharmaceuticals assets are valued at approximately $11.6 million TEL AVIV, Israel, July 08, 2024 (GLOBE...
DUBAI, United Arab Emirates, July 07, 2024 (GLOBE NEWSWIRE) -- At DP World's Aviv Clinics Dubai, the world’s most advanced...
Press Release STALICLA’s precision psychiatry study highlights strong EEG-based target engagement of STP1 treatment in defined subgroup of patients with...
AUSTIN, TX / ACCESSWIRE / June 21, 2024 / Action Behavior Centers is thrilled to announce the establishment of the...
CNM-Au8 demonstrated neuroprotective effects in an in vitro model of Rett Syndrome, a rare pediatric neurodevelopmental diseaseCNM-Au8 also demonstrated rescue...
FORT LAUDERDALE, Fla., June 17, 2024 /PRNewswire/ -- This weekend, Ernst & Young LLP (EY US) named Christopher Barnett, Founder &...
BERWYN, Pa.--(BUSINESS WIRE)--Titan CEO and headline sponsor Wipfli LLP are pleased to announce Bill Oldham, chairman and president, AscellaHealth, as a...
Receiving Orphan Drug Designation for SPG601 emphasizes the pressing demand for novel therapies for individuals living with Fragile X SyndromeSAN...
AUSTIN, TX / ACCESSWIRE / May 9, 2024 / Action Behavior Centers, a leading provider of applied behavior analysis (ABA)...
AUSTIN, TX / ACCESSWIRE / May 9, 2024 / Action Behavior Centers, a leading provider of applied behavior analysis (ABA)...
LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. today announced its acceptance into the 2024 cohort of the...
TARRYTOWN, New York, May 07, 2024 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (OTC:PXMD), a biopharmaceutical company focused on advancing...